Gossamer Bio, Inc. (4GB)
Munich
10.88
+10.74 (+7,589.05%)
Real-time Data
06:00 AM
Day's Range
10.8810.88
52 wk Range
0.141510.88
Financial Statements - 4GB - Gossamer Bio, Inc.
Revenue
48.47M▼ 57.7%
Net Income
-170.37M▼ 201.4%Net Margin -351.5%
EBITDA
-150.99M▼ 277.8%
Free Cash Flow
-171.34M▼ 4840.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 48.47M | 114.70M | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -163.25M | -59.91M | -173.75M | -213.14M | -210.72M | -205.39M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 1.81M | 14.02M | 5.45M | 1.41M | 706.17K | -22.97M |
| Pre Tax Income | -170.45M | -55.63M | -179.81M | -223.73M | -228.24M | -237.36M |
| Income Tax | -88K | 893K | - | - | - | - |
| Net Income | -170.37M | -56.52M | -179.81M | -223.73M | -228.24M | -237.36M |
| EPS Basic | -0.75 | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| EPS Diluted | -0.75 | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| Basic Shares Outstanding | 228.51M | 226.22M | 166.42M | 84.57M | 74.84M | 68.51M |
| Diluted Shares Outstanding | 228.51M | 226.22M | 166.42M | 84.57M | 74.84M | 68.51M |
| Ebit | -159.46M | -44.11M | -166.30M | -210.19M | -209.28M | -225.01M |
| Ebitda | -150.99M | -39.96M | -151.92M | -205.80M | -204.16M | -198.04M |
| Net Income Continuous Operations | -170.37M | -56.52M | -179.81M | -223.73M | -228.24M | -237.36M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
